BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34642805)

  • 1. Diffusion kurtosis imaging and dynamic contrast-enhanced MRI for the differentiation of parotid gland tumors.
    Huang N; Chen Y; She D; Xing Z; Chen T; Cao D
    Eur Radiol; 2022 Apr; 32(4):2748-2759. PubMed ID: 34642805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
    Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
    Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic efficacy of diffusion-weighted imaging and semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging in salivary gland tumors.
    Gökçe E; Beyhan M
    World J Radiol; 2023 Jan; 15(1):20-31. PubMed ID: 36721673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI.
    Yabuuchi H; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Hino T; Murayama Y; Yasumatsu R; Yamamoto H
    Eur Radiol; 2020 Dec; 30(12):6402-6412. PubMed ID: 32613285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravoxel Incoherent Motion Magnetic Resonance Imaging for Assessing Parotid Gland Tumors: Correlation and Comparison with Arterial Spin Labeling Imaging.
    Ma G; Xu XQ; Zhu LN; Jiang JS; Su GY; Hu H; Bu SS; Wu FY
    Korean J Radiol; 2021 Feb; 22(2):243-252. PubMed ID: 32932565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
    Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
    Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional, diffusion, and dynamic contrast-enhanced MRI findings for differentiating metaplastic Warthin's tumor of the parotid gland.
    Jia CH; Wang SY; Li Q; Qiu JM; Kuai XP
    Sci Prog; 2021; 104(2):368504211018583. PubMed ID: 34003684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
    Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
    Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Diffusion Kurtosis Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Differentiating Benign and Malignant Head and Neck Lesions.
    Cheng J; Shao S; Chen W; Zheng N
    J Magn Reson Imaging; 2022 Feb; 55(2):414-423. PubMed ID: 34378259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of pre-/post-contrast-enhanced T1 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging in differentiating parotid gland tumors.
    Wen B; Zhang Z; Fu K; Zhu J; Liu L; Gao E; Qi J; Zhang Y; Cheng J; Qu F; Zhu J
    Eur J Radiol; 2023 May; 162():110748. PubMed ID: 36905715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Intravoxel Incoherent Motion (IVIM) and Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Differentiation of Benign Parotid Gland Tumors.
    Markiet K; Glinska A; Nowicki T; Szurowska E; Mikaszewski B
    Biology (Basel); 2022 Mar; 11(3):. PubMed ID: 35336773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
    Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
    Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging for Differentiation Between Parotid Neoplasms.
    Elmokadem AH; Abdel Khalek AM; Abdel Wahab RM; Tharwat N; Gaballa GM; Elata MA; Amer T
    Can Assoc Radiol J; 2019 Aug; 70(3):264-272. PubMed ID: 30922790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
    Wang Y; Song L; Guo J; Xian J
    Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality fMRI with perfusion, diffusion-weighted MRI and
    Zhu L; Wang J; Shi H; Tao X
    J Magn Reson Imaging; 2019 Feb; 49(2):423-432. PubMed ID: 30475438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging biomarkers in the diagnosis of salivary gland tumors: the value of lesion/parenchyma ratio of perfusion-MR pharmacokinetic parameters.
    Mungai F; Verrone GB; Bonasera L; Bicci E; Pietragalla M; Nardi C; Berti V; Mazzoni LN; Miele V
    Radiol Med; 2021 Oct; 126(10):1345-1355. PubMed ID: 34181206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.